急性胰腺炎的细胞发病机制研究进展

侯文杰; 王美堂

doi:10.13201/j.issn.1009-5918.2023.05.009

急性胰腺炎的细胞发病机制研究进展

侯文杰¹,
王美堂^1,Δ, ,

- 海军军医大学长海医院急诊科(上海，200433)
基金项目:
海军军医大学第一附属医院“234学科攀峰计划”项目(No: 2020YXK038)

详细信息

通讯作者: 王美堂，E-mail：wmt88@sina.com

^△审校者

中图分类号: R657.51

收稿日期: 2022-06-10

刊出日期: 2023-05-10

Advances in cellular pathogenesis of acute pancreatitis

HOU Wenjie¹,
WANG Meitang^1,Δ, ,

- Department of Emergency, Changhai Hospital of Naval Military Medical University, Shanghai, 200433, China

More Information

Corresponding author: WANG Meitang, E-mail: wmt88@sina.com

Received Date: 10 June 2022

Publish Date: 10 May 2023

摘要

摘要: 急性胰腺炎(AP)是急诊常见的胰腺炎症性疾病，全球发病率约为34/10万，重症患者预后较差，病死率可达20%~40%。AP的发病机制尚未完全阐明，近年来研究发现，除胰蛋白酶原异常激活外，病理性钙信号、线粒体功能障碍、内质网应激、自噬受损等细胞事件在AP的发生发展中具有重要作用。目前AP的治疗主要是液体复苏、器官支持和并发症处理等，尚无特效治疗药物，了解AP细胞发病机制有助于为其治疗提供新思路，开发新靶点。因此，本文旨在对AP的细胞发病机制作一综述，为其治疗提供新思路。
- 急性胰腺炎 /
- 发病机制 /
- 胰腺腺泡细胞 /
- 研究进展
Abstract: Acute pancreatitis(AP) is a common inflammatory disease of the pancreas in the emergency department with a global incidence of about 34/100, 000 and a poor prognosis for severe patients whose mortality rate is 20% to 40%. The pathogenesis of AP has not been fully elucidated. In addition to abnormal activation of trypsinogen, recent studies that cellular events such as pathological calcium signalling, mitochondrial dysfunction, endoplasmic reticulum stress, and impaired autophagy play an important role in the occurrence and development of AP. At present, the treatment of AP is mainly fluid resuscitation, organ support and complication management, there is no effective drug for AP. Understanding the cellular mechanisms of AP may help to provide new ideas for its treatment and identify new targets. Therefore, the purpose of this paper is to review the cellular pathogenesis of AP and provide new ideas for its treatment.
- acute pancreatitis /
- pathogenesis mechanisms /
- pancreatic acinar cell /
- research advances

HTML全文

参考文献(53)

[1]	范正阳, 吴东. 急性胰腺炎早期抗炎治疗研究进展[J]. 内科急危重症杂志, 2022, 28(1): 11-14.
[2]	Lee PJ, Papachristou GI. New insights into acute pancreatitis[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(8): 479-496. doi: 10.1038/s41575-019-0158-2
[3]	Bang JY, Wilcox CM, Arnoletti JP, et al. Superiority of endoscopic interventions over minimally invasive surgery for infected necrotizing pancreatitis: meta-analysis of randomized trials[J]. Dig Endosc, 2020, 32(3): 298-308. doi: 10.1111/den.13470
[4]	Zhi MM, Zhu XY, Lugea A, et al. Incidence of new onset diabetes mellitus secondary to acute pancreatitis: a systematic review and meta-analysis[J]. Front Physiol, 2019, 10: 637. doi: 10.3389/fphys.2019.00637
[5]	Huang W, de la Iglesia-García D, Baston-Rey I, et al. Exocrine pancreatic insufficiency following acute pancreatitis: systematic review and meta-analysis[J]. Dig Dis Sci, 2019, 64(7): 1985-2005. doi: 10.1007/s10620-019-05568-9
[6]	Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(3): 175-184. doi: 10.1038/s41575-018-0087-5
[7]	Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis[J]. Lancet, 2020, 396(10252): 726-734. doi: 10.1016/S0140-6736(20)31310-6
[8]	Gukovskaya AS, Gorelick FS, Groblewski GE, et al. Recent insights into the pathogenic mechanism of pancreatitis: role of acinar cell organelle disorders[J]. Pancreas, 2019, 48(4): 459-470. doi: 10.1097/MPA.0000000000001298
[9]	Pallagi P, Madácsy T, Varga Á, et al. Intracellular Ca²⁺signalling in the pathogenesis of acute pancreatitis: recent advances and translational perspectives[J]. Int J Mol Sci, 2020, 21(11): 4005. doi: 10.3390/ijms21114005
[10]	Diszházi G, Magyar Zé, Lisztes E, et al. TRPM4 links calcium signaling to membrane potential in pancreatic acinar cells[J]. J Biol Chem, 2021, 297(3): 101015. doi: 10.1016/j.jbc.2021.101015
[11]	Kim SH, Park Y, Lim JW, et al. Effect of docosahexaenoic acid on Ca²⁺signaling pathways in cerulein-treated pancreatic acinar cells, determined by RNA-sequencing analysis[J]. Nutrients, 2019, 11(7): 1445. doi: 10.3390/nu11071445
[12]	Kim KM, Rana A, Park CY. Orai1 inhibitor STIM2β regulates myogenesis by controlling SOCE dependent transcriptional factors[J]. Sci Rep, 2019, 9(1): 10794. doi: 10.1038/s41598-019-47259-5
[13]	Yu F, Machaca K. The STIM1 phosphorylation Saga[J]. Cell Calcium, 2022, 103: 102551. doi: 10.1016/j.ceca.2022.102551
[14]	Romac JM, Shahid RA, Swain SM, et al. Piezo1 is a mechanically activated ion channel and mediates pressure induced pancreatitis[J]. Nat Commun, 2018, 9(1): 1715. doi: 10.1038/s41467-018-04194-9
[15]	Lai A, Cox CD, Chandra Sekar N, et al. Mechanosensing by Piezo1 and its implications for physiology and various pathologies[J]. Biol Rev Camb Philos Soc, 2022, 97(2): 604-614. doi: 10.1111/brv.12814
[16]	Swain SM, Romac JM, Shahid RA, et al. TRPV4 channel opening mediates pressure-induced pancreatitis initiated by Piezo1 activation[J]. J Clin Invest, 2020, 130(5): 2527-2541. doi: 10.1172/JCI134111
[17]	Han TY, Cheng T, Liu BF, et al. Evaluation of the prognostic value of red cell distribution width to total serum calcium ratio in patients with acute pancreatitis[J]. Gastroenterol Res Pract, 2021, 2021: 6699421.
[18]	Barakat MT, Khalid A, Yu M, et al. A review of the rationale for the testing of the calcineurin inhibitor tacrolimus for post-ERCP pancreatitis prevention[J]. Pancreatology, 2022, 22(6): 678-682. doi: 10.1016/j.pan.2022.07.003
[19]	Huang W, Cane MC, Mukherjee R, et al. Caffeine protects against experimental acute pancreatitis by inhibition of inositol 1, 4, 5-trisphosphate receptor-mediated Ca²⁺ release[J]. Gut, 2017, 66(2): 301-313. doi: 10.1136/gutjnl-2015-309363
[20]	Du WY, Liu G, Shi N, et al. A microRNA checkpoint for Ca²⁺ signaling and overload in acute pancreatitis[J]. Mol Ther, 2022, 30(4): 1754-1774. doi: 10.1016/j.ymthe.2022.01.033
[21]	Waldron RT, Chen YF, Pham H, et al. The Orai Ca²⁺ channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis[J]. J Physiol, 2019, 597(12): 3085-3105. doi: 10.1113/JP277856
[22]	Saluja A, Dudeja V, Dawra R, et al. Early intra-acinar events in pathogenesis of pancreatitis[J]. Gastroenterology, 2019, 156(7): 1979-1993. doi: 10.1053/j.gastro.2019.01.268
[23]	Hirota M, Ohmuraya M, Hashimoto D, et al. Roles of autophagy and pancreatic secretory trypsin inhibitor in trypsinogen activation in acute pancreatitis[J]. Pancreas, 2020, 49(4): 493-497. doi: 10.1097/MPA.0000000000001519
[24]	Wang JH, Wang LC, Zhang XF, et al. Cathepsin B aggravates acute pancreatitis by activating the NLRP3 inflammasome and promoting the caspase-1-induced pyroptosis[J]. Int Immunopharmacol, 2021, 94: 107496. doi: 10.1016/j.intimp.2021.107496
[25]	Talukdar R, Sareen A, Zhu HY, et al. Release of cathepsin B in cytosol causes cell death in acute pancreatitis[J]. Gastroenterology, 2016, 151(4): 747-758. e5. doi: 10.1053/j.gastro.2016.06.042
[26]	Boonchan M, Arimochi H, Otsuka K, et al. Necroptosis protects against exacerbation of acute pancreatitis[J]. Cell Death Dis, 2021, 12(6): 601. doi: 10.1038/s41419-021-03847-w
[27]	Duan PY, Ma Y, Li XN, et al. Inhibition of RIPK1-dependent regulated acinar cell necrosis provides protection against acute pancreatitis via the RIPK1/NF-κB/AQP8 pathway[J]. Exp Mol Med, 2019, 51(8): 1-17.
[28]	Sun BS, Chen Z, Chi Q, et al. Endogenous tRNA-derived small RNA(tRF3-Thr-AGT)inhibits ZBP1/NLRP3 pathway-mediated cell pyroptosis to attenuate acute pancreatitis(AP)[J]. J Cell Mol Med, 2021, 25(22): 10441-10453. doi: 10.1111/jcmm.16972
[29]	Wu JX, Zhang JT, Zhao JP, et al. Treatment of severe acute pancreatitis and related lung injury by targeting gasdermin D-mediated pyroptosis[J]. Front Cell Dev Biol, 2021, 9: 780142. doi: 10.3389/fcell.2021.780142
[30]	Sendler M, Weiss FU, Golchert J, et al. Cathepsin B-mediated activation of trypsinogen in endocytosing macrophages increases severity of pancreatitis in mice[J]. Gastroenterology, 2018, 154(3): 704-718. e10. doi: 10.1053/j.gastro.2017.10.018
[31]	Farooq A, Hernandez L, Swain SM, et al. Initiation and severity of experimental pancreatitis are modified by phosphate[J]. Am J Physiol Gastrointest Liver Physiol, 2022, 322(6): G561-G570. doi: 10.1152/ajpgi.00022.2022
[32]	Vanasco V, Ropolo A, Grasso D, et al. Mitochondrial dynamics and VMP1-related selective mitophagy in experimental acute pancreatitis[J]. Front Cell Dev Biol, 2021, 9: 640094. doi: 10.3389/fcell.2021.640094
[33]	Tóth E, Maléth J, Závogyán N, et al. Novel mitochondrial transition pore inhibitor N-methyl-4-isoleucine cyclosporin is a new therapeutic option in acute pancreatitis[J]. J Physiol, 2019, 597(24): 5879-5898. doi: 10.1113/JP278517
[34]	Patel P, Mendoza A, Robichaux DJ, et al. Inhibition of the anti-apoptotic bcl-2 family by BH3 mimetics sensitize the mitochondrial permeability transition pore through Ba_xand bak[J]. Front Cell Dev Biol, 2021, 9: 765973. doi: 10.3389/fcell.2021.765973
[35]	Zhang J, Huang WG, He QK, et al. PINK1/PARK2 dependent mitophagy effectively suppresses NLRP3 inflammasome to alleviate acute pancreatitis[J]. Free Radic Biol Med, 2021, 166: 147-164. doi: 10.1016/j.freeradbiomed.2021.02.019
[36]	Hunt EG, Andrews AM, Larsen SR, et al. The ER-mitochondria interface as a dynamic hub for T cell efficacy in solid tumors[J]. Front Cell Dev Biol, 2022, 10: 867341. doi: 10.3389/fcell.2022.867341
[37]	Li H, Wen W, Luo J. Targeting endoplasmic reticulum stress as an effective treatment for alcoholic pancreatitis[J]. Biomedicines, 2022, 10(1): 108. doi: 10.3390/biomedicines10010108
[38]	Lukas J, Pospech J, Oppermann C, et al. Role of endoplasmic reticulum stress and protein misfolding in disorders of the liver and pancreas[J]. Adv Med Sci, 2019, 64(2): 315-323. doi: 10.1016/j.advms.2019.03.004
[39]	Lebeau P, Byun JH, Yousof T, et al. Pharmacologic inhibition of S1P attenuates ATF6 expression, causes ER stress and contributes to apoptotic cell death[J]. Toxicol Appl Pharmacol, 2018, 349: 1-7. doi: 10.1016/j.taap.2018.04.020
[40]	He J, Ma MM, Li DM, et al. Sulfiredoxin-1 attenuates injury and inflammation in acute pancreatitis through the ROS/ER stress/Cathepsin B axis[J]. Cell Death Dis, 2021, 12(7): 626. doi: 10.1038/s41419-021-03923-1
[41]	Han X, Li B, Bao JP, et al. Endoplasmic reticulum stress promoted acinar cell necroptosis in acute pancreatitis through cathepsinB-mediated AP-1 activation[J]. Front Immunol, 2022, 13: 968639. doi: 10.3389/fimmu.2022.968639
[42]	Wu HX, Li H, Wen W, et al. MANF protects pancreatic acinar cells against alcohol-induced endoplasmic reticulum stress and cellular injury[J]. J Hepatobiliary Pancreat Sci, 2021, 28(10): 883-892. doi: 10.1002/jhbp.928
[43]	Cárdenas-Jaén K, Vaillo-Rocamora A, Gracia Á, et al. Simvastatin in the prevention of recurrent pancreatitis: design and rationale of a multicenter triple-blind randomized controlled trial, the SIMBA trial[J]. Front Med(Lausanne), 2020, 7: 494.
[44]	Iwahashi K, Hikita H, Makino Y, et al. Autophagy impairment in pancreatic acinar cells causes zymogen granule accumulation and pancreatitis[J]. Biochem Biophys Res Commun, 2018, 503(4): 2576-2582. doi: 10.1016/j.bbrc.2018.07.018
[45]	Mercer TJ, Ohashi Y, Boeing S, et al. Phosphoproteomic identification of ULK substrates reveals VPS15-dependent ULK/VPS34 interplay in the regulation of autophagy[J]. EMBO J, 2021, 40(14): e105985. doi: 10.15252/embj.2020105985
[46]	Yan RL, Luan CL, Liao CC, et al. Long noncoding RNA BCRP3 stimulates VPS34 and autophagy activities to promote protein homeostasis and cell survival[J]. J Biomed Sci, 2022, 29(1): 30. doi: 10.1186/s12929-022-00815-0
[47]	Li HY, Lin YJ, Zhang L, et al. Autophagy in intestinal injury caused by severe acute pancreatitis[J]. Chin Med J(Engl), 2021, 134(21): 2547-2549.
[48]	Piplani H, Marek-Iannucci S, Sin J, et al. Simvastatin induces autophagic flux to restore cerulein-impaired phagosome-lysosome fusion in acute pancreatitis[J]. Biochim Biophys Acta Mol Basis Dis, 2019, 1865(11): 165530. doi: 10.1016/j.bbadis.2019.08.006
[49]	Yuan XH, Wu J, Guo X, et al. Autophagy in acute pancreatitis: organelle interaction and microRNA regulation[J]. Oxid Med Cell Longev, 2021, 2021: 8811935.
[50]	Iwama H, Mehanna S, Imasaka M, et al. Cathepsin B and D deficiency in the mouse pancreas induces impaired autophagy and chronic pancreatitis[J]. Sci Rep, 2021, 11(1): 6596. doi: 10.1038/s41598-021-85898-9
[51]	Feng DC, Park O, Radaeva S, et al. Interleukin-22 ameliorates cerulein-induced pancreatitis in mice by inhibiting the autophagic pathway[J]. Int J Biol Sci, 2012, 8(2): 249-257. doi: 10.7150/ijbs.3967
[52]	Choi S, Kim H. The remedial potential of lycopene in pancreatitis through regulation of autophagy[J]. Int J Mol Sci, 2020, 21(16): 5775. doi: 10.3390/ijms21165775
[53]	Pupyshev AB, Klyushnik TP, Akopyan AA, et al. Disaccharide trehalose in experimental therapies for neurodegenerative disorders: molecular targets and translational potential[J]. Pharmacol Res, 2022, 183: 106373. doi: 10.1016/j.phrs.2022.106373